216 related articles for article (PubMed ID: 37196635)
1. Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.
Hawtin S; André C; Collignon-Zipfel G; Appenzeller S; Bannert B; Baumgartner L; Beck D; Betschart C; Boulay T; Brunner HI; Ceci M; Deane J; Feifel R; Ferrero E; Kyburz D; Lafossas F; Loetscher P; Merz-Stoeckle C; Michellys P; Nuesslein-Hildesheim B; Raulf F; Rush JS; Ruzzante G; Stein T; Zaharevitz S; Wieczorek G; Siegel R; Gergely P; Shisha T; Junt T
Cell Rep Med; 2023 May; 4(5):101036. PubMed ID: 37196635
[TBL] [Abstract][Full Text] [Related]
2. First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults.
Shisha T; Posch MG; Lehmann J; Feifel R; Junt T; Hawtin S; Schuemann J; Avrameas A; Danekula R; Misiolek P; Siegel R; Gergely P
Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):553-566. PubMed ID: 37532923
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases.
Deshmukh A; Pereira A; Geraci N; Tzvetkov E; Przetak M; Catalina MD; Morand EF; Bender AT; Vaidyanathan B
J Pharmacol Exp Ther; 2024 Feb; 388(3):751-764. PubMed ID: 37673681
[TBL] [Abstract][Full Text] [Related]
4. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus.
Anders HJ; Krug A; Pawar RD
Eur J Immunol; 2008 Jul; 38(7):1795-9. PubMed ID: 18581336
[TBL] [Abstract][Full Text] [Related]
6. Effect of
Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D
Front Immunol; 2019; 10():275. PubMed ID: 30846987
[No Abstract] [Full Text] [Related]
7. Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.
Yu SL; Chan PK; Wong CK; Szeto CC; Ho SC; So K; Yu MM; Yim SF; Cheung TH; Wong MC; Cheung JL; Yeung AC; Li EK; Tam LS
Arthritis Res Ther; 2012 Apr; 14(2):R80. PubMed ID: 22513098
[TBL] [Abstract][Full Text] [Related]
8. Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune Diseases.
Alper P; Betschart C; André C; Boulay T; Cheng D; Deane J; Faller M; Feifel R; Glatthar R; Han D; Hemmig R; Jiang T; Knoepfel T; Maginnis J; Mutnick D; Pei W; Ruzzante G; Syka P; Zhang G; Zhang Y; Zink F; Zipfel G; Hawtin S; Junt T; Michellys PY
ACS Med Chem Lett; 2023 Aug; 14(8):1054-1062. PubMed ID: 37583811
[TBL] [Abstract][Full Text] [Related]
9. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.
Smith N; Rodero MP; Bekaddour N; Bondet V; Ruiz-Blanco YB; Harms M; Mayer B; Bader-Meunier B; Quartier P; Bodemer C; Baudouin V; Dieudonné Y; Kirchhoff F; Sanchez Garcia E; Charbit B; Leboulanger N; Jahrsdörfer B; Richard Y; Korganow AS; Münch J; Nisole S; Duffy D; Herbeuval JP
Sci Adv; 2019 Jul; 5(7):eaav9019. PubMed ID: 31309143
[TBL] [Abstract][Full Text] [Related]
10. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
Celhar T; Lu HK; Benso L; Rakhilina L; Lee HY; Tripathi S; Zharkova O; Ong WY; Yasuga H; Au B; Marlier D; Lim LHK; Thamboo TP; Mudgett JS; Mackey MF; Zaller DM; Connolly JE; Fairhurst AM
Front Immunol; 2019; 10():1546. PubMed ID: 31354711
[TBL] [Abstract][Full Text] [Related]
11. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.
Guiducci C; Tripodo C; Gong M; Sangaletti S; Colombo MP; Coffman RL; Barrat FJ
J Exp Med; 2010 Dec; 207(13):2931-42. PubMed ID: 21115693
[TBL] [Abstract][Full Text] [Related]
13. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation.
Takagi H; Arimura K; Uto T; Fukaya T; Nakamura T; Choijookhuu N; Hishikawa Y; Sato K
Sci Rep; 2016 Apr; 6():24477. PubMed ID: 27075414
[TBL] [Abstract][Full Text] [Related]
15. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
16. Endosomal Toll-like receptors in clinically overt and silent autoimmunity.
Clancy RM; Markham AJ; Buyon JP
Immunol Rev; 2016 Jan; 269(1):76-84. PubMed ID: 26683146
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
Front Immunol; 2018; 9():1957. PubMed ID: 30210502
[No Abstract] [Full Text] [Related]
18. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
19. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
Yim LY; Lau CS; Chan VS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.
Panda SK; Facchinetti V; Voynova E; Hanabuchi S; Karnell JL; Hanna RN; Kolbeck R; Sanjuan MA; Ettinger R; Liu YJ
J Clin Invest; 2018 May; 128(5):1873-1887. PubMed ID: 29611821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
